The reasons are multifactorial: chronic inflammation damages blood vessel walls, corticosteroid use raises cholesterol and blood pressure, lupus-specific antibodies (particularly antiphospholipid antibodies) increase clotting risk, and the metabolic disruption caused by both the disease and its treatments creates a perfect storm for atherosclerosis
When compared head-to-head with a semaglutide surrogate at equivalent molar doses over 28 days, the optimized FGF21 analog surpassed the GLP-1 agonist by day 11 and ultimately achieved 43 percent absolute body weight reduction versus 30 percent for the incretin
The vast majority clustered within a relatively narrow range around the average
However, further studies are required to elucidate underlying mechanisms and confirm clinical applicability
Published research on GHK-Cu has linked it to tissue remodeling, collagen synthesis, fibroblast support, anti-inflammatory activity, and broader regenerative signaling
By reducing hunger, it supports meaningful, long-term weight loss